Alvogen has completed the sale of its central and eastern European business to Zentiva. The deal – first announced in October Also see "Zentiva Snaps Up Alvogen’s CEE Operations" - Generics Bulletin, 25 October, 2019. – has seen Alvogen sell over 200 generic and over-the-counter products across multiple therapeutic areas consisting of brands such as Lactacyd, Persen, EuBiotic and covering 14 key markets, for an undisclosed value.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?